Estramustine Reduces Invasion of Glioblastoma Cells
Author Information
Author(s): D Yoshida, JM Piepmeier, T Bergenheim, R Henriksson, A Teramoto
Primary Institution: Nippon Medical School
Hypothesis
Does estramustine affect matrix metalloproteinase-2 activity and cell invasion in glioma cells?
Conclusion
Estramustine phosphate inhibits the secretion of matrix metalloproteinases-2 and the invasiveness of human glioblastoma cells in vitro.
Supporting Evidence
- An activated form of matrix metalloproteinase-2 diminished with increasing estramustine concentrations.
- Collagenolysis assay showed 2.5- to 21-fold lower rates of enzymatic activity suppressed by estramustine.
- Haptoinvasion assay revealed significant suppression of invasion in a dose-dependent manner with estramustine.
Takeaway
Estramustine is a drug that helps stop brain cancer cells from spreading by reducing a specific protein that helps them invade other tissues.
Methodology
The study used cell proliferation assays, zymograms, collagenolysis assays, and haptoinvasion assays to evaluate the effects of estramustine on glioma cells.
Limitations
The study did not examine the effects of estramustine on other matrix metalloproteinases beyond MMP-2.
Participant Demographics
Human glioblastoma cells (U87MG) were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website